Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Published byPatrick Moody Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair."— Presentation transcript:

1 Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair. Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies?☆ Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

2 Table 1 Comparison of baseline characteristics.
Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies?☆ Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

3 Table 2 Comparison of operative characteristics.
Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies?☆ Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

4 Table 3 Cost comparison between Surgical repair and TEVAR.
Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies?☆ Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

5 Table 4 Comparison of mortality and morbidity.
Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies?☆ Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

6 Table 5 Risk of re-intervention and late death.
Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies?☆ Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

7 Fig. 2 Log-rank test comparing freedom from re-intervention in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair. Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies?☆ Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Download ppt "Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair."

Similar presentations

P Narayan, A Wong, I Davies, A J Bryan, P Wilde, G J Murphy Does TEVAR provide a financial benefit for management of descending thoracic aortic pathologies?

P Narayan, A Wong, I Davies, A J Bryan, P Wilde, G J Murphy Does TEVAR provide a financial benefit for management of descending thoracic aortic pathologies?
Fig.1 Complexity of the surgeries according to BAS. Histogram.

Fig.1 Complexity of the surgeries according to BAS. Histogram.
V. G. Hadjianastassiou, P. P. Tekkis, T. Athanasiou, A. Muktadir, J. D

V. G. Hadjianastassiou, P. P. Tekkis, T. Athanasiou, A. Muktadir, J. D
Jan L.Svennevig, MD,PhD j.l.svennevig@medisin.uio.no Heart surgery in Norway 2009 Norwegian Association for Cardiothoracic Surgery Jan L.Svennevig, MD,PhD.

Jan L.Svennevig, MD,PhD Heart surgery in Norway 2009 Norwegian Association for Cardiothoracic Surgery Jan L.Svennevig, MD,PhD.
Figure 1: A PRISMA schematic of search strategy

Figure 1: A PRISMA schematic of search strategy
Fig. 1. TGF results in different group

Fig. 1. TGF results in different group
Table 1 Cause of death for arrested organ donors

Table 1 Cause of death for arrested organ donors
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
Fig. 1. Patient transferred to ICU with IABP inserted surgically through left axillary artery approached at deltoido-pectoralis groove (a). Correct position.

Fig. 1. Patient transferred to ICU with IABP inserted surgically through left axillary artery approached at deltoido-pectoralis groove (a). Correct position.
Table 1 Patient characteristics

Table 1 Patient characteristics
Fig. 1 Clinical model of coronary collateral flow

Fig. 1 Clinical model of coronary collateral flow
Table 1 Staging of resected tumours of the oesophagus

Table 1 Staging of resected tumours of the oesophagus
Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.

Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.
Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.
Table 1 Comparison of perioperative patient characteristics by groups

Table 1 Comparison of perioperative patient characteristics by groups
Device-specific Outcomes Following Endovascular Aortic Aneurysm Repair

Device-specific Outcomes Following Endovascular Aortic Aneurysm Repair
Table 1 Hospital mortality

Table 1 Hospital mortality
John A. Elefteriades, MD, Andrew Percy 

John A. Elefteriades, MD, Andrew Percy 
Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.

Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.
From: Long-term respiratory functional results after pneumonectomy

From: Long-term respiratory functional results after pneumonectomy

Similar presentations

Ads by Google